QIAGEN N.V. QGEN has secured FDA clearance for its QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use, bolstering its syndromic testing portfolio in the United States. This marks the ...
It is designed to complement the QIAstat-Dx Gastrointestinal Panel 2 Mini B&V (Bacterial & Viral) that covers Campylobacter, Salmonella, Shiga-like toxin-producing Escherichia coli (STEC ...
QIAGEN building momentum in the U.S. syndromic testing market with six regulatory clearance of panels for use on QIAstat-Dx within the last 10 months GERMANTOWN, Md ...
Qiagen (QGEN) announced that the FDA has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use. This marks Qiagen’s second FDA clearance of a QIAstat-Dx panel in 2025 ...
Jaipur: To ensure that people do not face any problems related to drinking water in any part of the state during the summer, ...
GlobalData on MSN20d
FDA clears Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini BThe US Food and Drug Administration (FDA) has granted clearance to Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B, ...
The panel industry is monitoring developments closely, as recent improvements in demand have raised concerns about a possible ...
The ancient handloom art of Tangaliya, which is over 700 years old, is practiced by the Dangasia community of Surendranagar district. Lavji bhai Nagji bhai Parmar is a beneficiary of Project HMI and ...
Japanese company Toppan Holdings has decided to divest all its 53.1% stake in Taiwan-based Giantplus Technology, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback